Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Medicinal Chemistry|April 22, 2024
Discovery of an Ortho-Substituted N-Cyclopropylmethyl-7α-phenyl-6,14-endoethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative EffectZixiang Li, Rufeng Ye, Qian He, et al.
Journal of Medicinal Chemistry|July 28, 2025
Structure-Activity Relationship of N-Cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor AgonistsLinghui Kong, Songyu Yao, Denggao Zhang, et al.
European Journal of Medicinal Chemistry|March 11, 2025
Structure-activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR/MOR activitiesSiyuan Tang, Shuyang Hu, Lijing Feng, et al.
Translational Andrology and Urology|July 12, 2026
Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with high-volume metastatic hormone-sensitive prostate cancer: a retrospective multicenter cohort studyBaojun Wang, Dan Xia, Yu Pan, et al.
Liver Cancer|August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective StudyDongdong Xia, Wei Bai, Enxin Wang, et al.
European Radiology|April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolizationDongdong Xia, Qiuhe Wang, Wei Bai, et al.
Journal of Hepatology|January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational studyQiuhe Wang, Dongdong Xia, Wei Bai, et al.
JHEP Reports : Innovation in Hepatology|January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆Dongdong Xia, Wei Bai, Qiuhe Wang, et al.
Pageof 9